ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2014

Statistical and regulatory considerations in assessments of interchangeability of biological drug products.

Lászlo Tóthfalusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.